Hill & Smith publishes 2025 annual report, revenue rises 2% to £868.8 million

HILLSTREAM BIOPHARMA, INC.

HILLSTREAM BIOPHARMA, INC.

HILS

0.00
  • Hill & Smith annual report for 2025 flagged strong momentum in larger US operations, supported by sustained infrastructure spending.
  • UK trading remained difficult, prompting a review of actions to strengthen UK operations amid weak demand visibility.
  • Capital allocation shifted toward capacity expansion in US transmission and distribution operations, targeting faster growth end markets such as data centers.
  • M&A pipeline stayed active, highlighted by agreed deals for Freeberg Industrial Fabrication and Hentech Fabrication signed in March 2026.
  • Group set out plans to switch reporting currency to US dollars from interim results for six months ending June 30, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hill & Smith plc published the original content used to generate this news brief on April 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.